| language |
eng
|
| Author |
Maruyama Dai
Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Tsukasaki Kunihiro
Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan
Uchida Toshiki
Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
Maeda Yoshinobu
Okayama University Hospital, Okayama, Japan View author publications
Shibayama Hirohiko
Osaka University Hospital, Osaka, Japan
Nagai Hirokazu
Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
Kurosawa Mitsutoshi
Hokkaido Cancer Center, Sapporo, Japan
Suehiro Yoko
Kyushu Cancer Center, Fukuoka, Japan
Hatake Kiyohiko
The Cancer Institute Hospital, Tokyo, Japan
Ando Kiyoshi
Tokai University Hospital, Isehara, Japan
Yoshida Isao
Shikoku Cancer Center, Matsuyama, Japan
Hidaka Michihiro
Kumamoto Medical Center, Kumamoto, Japan
Murayama Tohru
Hyogo Cancer Center, Akashi, Japan
Okitsu Yoko
Tohoku University Hospital, Sendai, Japan
Tsukamoto Norifumi
Gunma University Hospital, Maebashi, Japan
Taniwaki Masafumi
University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
Tamura Kazuo
Fukuoka University Hospital, Fukuoka, Japan
Yamauchi Takahiro
Fukui University Hospital, Fukui, Japan
Ueda Ryuzo
Aichi Medical University, Nagakute, Japan
Tobinai Kensei
Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
|
| Subject | Forodesine; Peripheral T cell lymphoma; Overall response rate; Progression-free survival; Purine nucleoside phosphorylase inhibitor
|
| Journal Title |
ANNALS OF HEMATOLOGY
|
| Volume | 98
|
| Issue | 1
|
| Start Page | 131
|
| End Page | 142
|
| ISSN | 0939-5555
|
| ISSN（Online） | 1432-0584
|
| Published Date | 2019-01
|
| DOI | |
| PubMed ID | |
| Publisher | SPRINGER
|
| NII Type |
Journal Article
|
| OAI-PMH Set |
Faculty of Medicine
|
| Remark | This work was supported by Mundipharma K.K., Tokyo, Japan.
|
